Rituximab Use for Relapse Prevention in Anti-NMDAR Antibody-Mediated Encephalitis: A Multicenter Cohort Study.

Saved in:
Bibliographic Details
Title: Rituximab Use for Relapse Prevention in Anti-NMDAR Antibody-Mediated Encephalitis: A Multicenter Cohort Study.
Authors: Seery N; Department of Neuroscience, Monash University, Melbourne, Australia.; Department of Neurology, Alfred Health, Melbourne, Australia., Wesselingh R; Department of Neuroscience, Monash University, Melbourne, Australia.; Department of Neurology, Alfred Health, Melbourne, Australia., Beech P; Department of Radiology, Alfred Health, Melbourne, Australia.; Department of Radiology, Monash Health, Melbourne, Australia., McLaughlin L; Department of Neurology, Princess Alexandra Hospital, Australia.; School of Medicine, The University of Queensland, Australia., Rushen T; Department of Neuroscience, Monash University, Melbourne, Australia.; Department of Neurology, Alfred Health, Melbourne, Australia., Halliday AJ; Department of Medicine, St Vincent's Hospital, University of Melbourne, Australia., Ter Horst L; Department of Neurology, Princess Alexandra Hospital, Australia.; School of Medicine, The University of Queensland, Australia., Griffith SP; Department of Neuroscience, Monash University, Melbourne, Australia.; Department of Neurology, Alfred Health, Melbourne, Australia., Forcadela M; Department of Neurology, Austin Health, Melbourne, Australia., Tan TH; Department of Neuroscience, Monash University, Melbourne, Australia.; Department of Neurology, Alfred Health, Melbourne, Australia., Kazzi C; Department of Neuroscience, Monash University, Melbourne, Australia.; Department of Neurology, Alfred Health, Melbourne, Australia., Nesbitt C; Department of Neurology, Alfred Health, Melbourne, Australia.; Department of Neuroscience, University Hospital Geelong, Geelong, Australia., Broadley J; Department of Neuroscience, Monash University, Melbourne, Australia.; Department of Neurology, Alfred Health, Melbourne, Australia., Buzzard K; Department of Neurosciences, Eastern Health, Melbourne, Australia., Duncan A; Department of Medicine, St Vincent's Hospital, University of Melbourne, Australia., D'Souza WJ; Department of Medicine, St Vincent's Hospital, University of Melbourne, Australia., Tran Y; Department of Medicine, St Vincent's Hospital, University of Melbourne, Australia.; Department of Pathology, St Vincent's Hospital, Melbourne, Australia., Van Der Walt A; Department of Neuroscience, Monash University, Melbourne, Australia.; Department of Neurology, Alfred Health, Melbourne, Australia., Skinner G; Department of Neurology, Princess Alexandra Hospital, Australia.; School of Medicine, The University of Queensland, Australia., Taylor BV; Department of Neurology, Royal Hobart Hospital, Australia., Swayne A; Department of Neurology, Princess Alexandra Hospital, Australia.; School of Medicine, The University of Queensland, Australia., Brodtmann A; Department of Neuroscience, Monash University, Melbourne, Australia.; Department of Neurosciences, Eastern Health, Melbourne, Australia.; Department of Neurology, Royal Melbourne Hospital, Australia., Gillis D; Division of Immunology, Pathology Queensland Central Laboratory, Herston, Australia., Butler EG; Department of Neurology, Peninsula Health, Australia., Kalincik T; CORe, Department of Medicine, The University of Melbourne, Australia.; Neuroimmunology Centre, Department of Neurology, Royal Melbourne Hospital, Australia., Seneviratne UK; Department of Neuroscience, Monash University, Melbourne, Australia.; Department of Medicine, St Vincent's Hospital, University of Melbourne, Australia.; Department of Neuroscience, Monash Health, Melbourne, Australia., Macdonell RA; Department of Neurology, Austin Health, Melbourne, Australia., Blum S; Department of Neurology, Princess Alexandra Hospital, Australia.; School of Medicine, The University of Queensland, Australia., Ramanathan S; Department of Neurology and Concord Clinical School, Concord Hospital, Australia.; Translational Neuroimmunology Group, Kids Neuroscience Centre and Brain and Mind Centre, Faculty of Medicine and Health, University of Sydney, Australia., Malpas CB; Department of Neuroscience, Monash University, Melbourne, Australia.; Department of Medicine (Royal Melbourne Hospital), University of Melbourne, Australia.; Melbourne School of Psychological Sciences, University of Melbourne, Australia; and., Reddel SW; Department of Neurology and Concord Clinical School, Concord Hospital, Australia.; Brain and Mind Centre, University of Sydney, Australia., Hardy TA; Department of Neurology and Concord Clinical School, Concord Hospital, Australia.; Brain and Mind Centre, University of Sydney, Australia., O'Brien TJ; Department of Neuroscience, Monash University, Melbourne, Australia.; Department of Neurology, Alfred Health, Melbourne, Australia., Sanfilippo PG; Department of Neuroscience, Monash University, Melbourne, Australia., Butzkueven H; Department of Neuroscience, Monash University, Melbourne, Australia.; Department of Neurology, Alfred Health, Melbourne, Australia., Monif M; Department of Neuroscience, Monash University, Melbourne, Australia.; Department of Neurology, Alfred Health, Melbourne, Australia.; Department of Neurology, Royal Melbourne Hospital, Australia.
Corporate Authors: Australian Autoimmune Encephalitis Consortium
Source: Neurology(R) neuroimmunology & neuroinflammation [Neurol Neuroimmunol Neuroinflamm] 2025 Jul; Vol. 12 (4), pp. e200395. Date of Electronic Publication: 2025 May 30.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Wolters Kluwer Health/Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101636388 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2332-7812 (Electronic) Linking ISSN: 23327812 NLM ISO Abbreviation: Neurol Neuroimmunol Neuroinflamm Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2332-7812
DOI:10.1212/NXI.0000000000200395